PART I Company Background Oncotelic Therapeutics, Inc. (f/k/a Mateon Therapeutics, Inc.) ( Oncotelic ), was formed in the State of New York in 1988 as OXiGENE, Inc., was reincorporated in the State of Delaware in 1992, and changed its name to Mateon Therapeutics, Inc. in 2016, and Oncotelic Therapeutics, Inc. in November 2020. Oncotelic conducts business activities through Oncotelic and its wholly-owned subsidiaries, Oncotelic, Inc., a Delaware corporation, PointR Data, Inc. ( PointR ), a Delawa...
Q2 FY2026 — expected 2026-08-13
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-04-15 | 2024-12-31 | 0001641172-25-004846 | EDGAR | 82K words |
| 2024-04-12 | 2023-12-31 | 0001493152-24-014475 | EDGAR | — |
| 2023-04-14 | 2022-12-31 | 0001493152-23-012352 | EDGAR | — |
| 2022-04-15 | 2021-12-31 | 0001493152-22-010094 | EDGAR | — |
| 2021-04-15 | 2020-12-31 | 0001493152-21-008920 | EDGAR | — |
| 2020-05-14 | 2019-12-31 | 0001493152-20-008845 | EDGAR | — |
| 2019-04-10 | 2018-12-31 | 0001193125-19-102832 | EDGAR | — |
| 2018-04-17 | 2017-12-31 | 0001193125-18-119206 | EDGAR | — |
| 2017-03-30 | 2016-12-31 | 0001193125-17-103621 | EDGAR | — |
| 2016-03-25 | 2015-12-31 | 0001193125-16-518083 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-17 | 2025-09-30 | 0001493152-25-023834 | EDGAR | 36K words |
| 2025-08-13 | 2025-06-30 | 0001641172-25-023568 | EDGAR | — |
| 2025-05-15 | 2025-03-31 | 0001641172-25-010984 | EDGAR | — |
| 2024-11-19 | 2024-09-30 | 0001493152-24-046867 | EDGAR | — |
| 2024-08-14 | 2024-06-30 | 0001493152-24-031995 | EDGAR | — |
| 2024-05-15 | 2024-03-31 | 0001493152-24-019332 | EDGAR | — |
| 2023-11-14 | 2023-09-30 | 0001493152-23-040804 | EDGAR | — |
| 2023-08-18 | 2023-06-30 | 0001493152-23-029461 | EDGAR | — |
| 2023-05-22 | 2023-03-31 | 0001493152-23-018430 | EDGAR | — |
| 2022-11-18 | 2022-09-30 | 0001493152-22-032950 | EDGAR | — |
| 2022-08-22 | 2022-06-30 | 0001493152-22-023658 | EDGAR | — |
| 2022-05-23 | 2022-03-31 | 0001493152-22-014681 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-04-02 | 0001493152-26-014831 | EDGAR | 12K words |
| 2026-03-30 | 0001493152-26-013503 | EDGAR | — |
| 2026-03-30 | 0001493152-26-013391 | EDGAR | — |
| 2026-01-29 | 0001493152-26-004237 | EDGAR | — |
| 2026-01-26 | 0001493152-26-003606 | EDGAR | — |
| 2026-01-07 | 0001493152-26-000821 | EDGAR | — |
| 2026-01-06 | 0001493152-26-000619 | EDGAR | — |
| 2026-01-06 | 0001493152-26-000613 | EDGAR | — |
| 2025-12-30 | 0001493152-25-029634 | EDGAR | — |
| 2025-12-23 | 0001493152-25-028921 | EDGAR | — |
514 total filings indexed. 482 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0000908259 |
| Ticker | OTLC |
| Exchange | OTC |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report